All Drugs Associated with Speech disorder (Page 3)
1,060 drugs have been associated with Speech disorder in FAERS reports.
| Drug | Reports | Deaths | Hosp. | Life-Threat. |
|---|---|---|---|---|
| IRINOTECAN | 133 | 16 | 35 | 4 |
| BUPROPION | 132 | 1 | 58 | 12 |
| PHENYTOIN | 132 | 5 | 71 | 5 |
| EVEROLIMUS | 131 | 23 | 51 | 13 |
| LEVOFLOXACIN | 128 | 8 | 68 | 20 |
| ESCITALOPRAM OXALATE | 127 | 1 | 70 | 7 |
| METHYLPHENIDATE | 127 | 2 | 27 | 10 |
| CODEINE | 126 | 3 | 72 | 29 |
| UPADACITINIB | 126 | 1 | 60 | 4 |
| PEMBROLIZUMAB | 124 | 24 | 76 | 25 |
| DIVALPROEX | 123 | 11 | 54 | 0 |
| BISOPROLOL | 122 | 2 | 72 | 9 |
| CLOPIDOGREL BISULFATE | 122 | 16 | 65 | 11 |
| ALEMTUZUMAB | 120 | 2 | 72 | 12 |
| ACETAMINOPHEN\HYDROCODONE | 119 | 10 | 39 | 3 |
| TREPROSTINIL | 119 | 9 | 67 | 5 |
| ZOLEDRONIC ACID | 116 | 6 | 55 | 4 |
| DABIGATRAN ETEXILATE | 115 | 5 | 88 | 13 |
| DIPHENHYDRAMINE | 115 | 9 | 57 | 8 |
| ACETAMINOPHEN\OXYCODONE | 114 | 7 | 37 | 1 |
| PREDNISOLONE | 114 | 17 | 71 | 35 |
| ENZALUTAMIDE | 113 | 19 | 40 | 1 |
| DENOSUMAB | 112 | 16 | 32 | 3 |
| MEPOLIZUMAB | 112 | 4 | 70 | 2 |
| IBRUTINIB | 111 | 4 | 60 | 0 |
| RUXOLITINIB | 111 | 17 | 51 | 6 |
| AMBRISENTAN | 108 | 9 | 58 | 0 |
| CYCLOSPORINE | 106 | 16 | 53 | 8 |
| NIRMATRELVIR\RITONAVIR | 106 | 2 | 11 | 5 |
| DABRAFENIB | 105 | 29 | 46 | 7 |
| EVOLOCUMAB | 105 | 0 | 18 | 5 |
| RAVULIZUMAB-CWVZ | 104 | 0 | 11 | 0 |
| DOXORUBICIN | 103 | 22 | 68 | 31 |
| METRONIDAZOLE | 102 | 0 | 46 | 12 |
| DEUTETRABENAZINE | 101 | 2 | 21 | 0 |
| HYDROMORPHONE | 100 | 19 | 55 | 7 |
| NILOTINIB | 100 | 13 | 49 | 10 |
| RISANKIZUMAB-RZAA | 100 | 2 | 36 | 1 |
| LEFLUNOMIDE | 99 | 1 | 25 | 6 |
| LEVODOPA | 98 | 5 | 21 | 0 |
| ZOLPIDEM | 98 | 3 | 52 | 6 |
| APOMORPHINE | 97 | 0 | 7 | 0 |
| LOSARTAN | 96 | 9 | 47 | 19 |
| LURASIDONE | 95 | 2 | 18 | 5 |
| TRAMETINIB DIMETHYL SULFOXIDE | 93 | 24 | 36 | 6 |
| LETROZOLE | 92 | 13 | 36 | 9 |
| SIMVASTATIN | 91 | 3 | 42 | 1 |
| NIVOLUMAB | 90 | 14 | 58 | 10 |
| VINCRISTINE | 90 | 17 | 58 | 34 |
| EDARAVONE | 89 | 3 | 2 | 0 |